Maslan Andrew Scott 4
4 · CYTOMEDIX INC · Filed Oct 21, 2010
Insider Transaction Report
Form 4
Maslan Andrew Scott
Chief Financial Officer
Transactions
- Other
Common Stock
2010-10-15+540→ 57,520 total
Footnotes (1)
- [F1]Received pursuant to a stock dividend on the Company's outstanding Series D Convertible Preferred Stock.